ssHepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicenter cohort study.
Margarita PapatheodoridiTung-Hung SuEmilia HadziyannisChun-Hsun LiaoΑfroditi OrfanidouHung-Chi YangKalliopi ZachouChun-Jen LiuAnastasia KourikouNikolaos GatselisSpilios ManolakopoulosGeorgios N DalekosJia-Horng KaoStephanos HadziyannisGeorgios PapatheodoridisPublished in: Liver international : official journal of the International Association for the Study of the Liver (2021)
Our findings suggest that discontinuation of effective long-term NA therapy in non-cirrhotic CHBe- patients is not associated with increased HCC risk, which is not affected by post-NA relapses and/or HBsAg loss.